The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity.
Phase of Trial: Phase I
Latest Information Update: 19 Jun 2012
At a glance
- Drugs Fluoxetine (Primary) ; Caffeine; Dextromethorphan; Midazolam; Omeprazole
- Indications Depressive disorders
- Focus Pharmacokinetics
- 19 Jun 2012 Actual end date (June 2012) added as reported by ClinicalTrials.gov.
- 19 Jun 2012 Actual patient number added 36 according to ClinicalTrials.gov.
- 19 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.